Fuji Pharma Co., Ltd. (TYO:4554)

Fuji Pharma Revenue

In the fiscal year ending September 30, 2026, Fuji Pharma had annual revenue of 62.39B JPY with 20.72% growth. Fuji Pharma had revenue of 17.00B in the quarter ending September 30, 2026, with 15.49% growth. That makes Fuji Pharma the 12,787th largest company in the world by revenue and 1,326th in Japan.

• Revenue: 62.39B
• Revenue Growth: +20.72%
• P/S Ratio: 0.78
• Revenue / Employee: 35.45M
• Employees: 1,760
• Market Cap: 48.50B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Sep 30, 2026	62.39B	10.71B	20.72%
Sep 30, 2025	51.68B	5.54B	12.01%
Sep 30, 2024	46.14B	5.25B	12.84%
Sep 30, 2023	40.89B	5.46B	15.42%
Sep 30, 2022	35.43B	1.44B	4.22%

Data Source: S&P Global Market Intelligence Last updated: Nov 10, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 15, 2026

Data Sources Report a data error